Skip to main content
SpringerLink
Log in

Levothyroxine Supplementation Following Hemithyroidectomy: Incidence, Risk Factors, and Characteristics

  • Endocrine Tumors
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

The goal of the present study was to determine the actual incidence, predictive risk factors, and clinical characteristics of levothyroxine supplementation (LT4S) used for the management of hypothyroidism after hemithyroidectomy.

Methods

From 2008 to 2015, we included 535 patients who underwent hemithyroidectomy. LT4S was initiated based on three major criteria: the development of overt hypothyroidism, subclinical hypothyroidism with thyroid-stimulating hormone (TSH) levels > 10 mIU/L, or subclinical hypothyroidism with TSH levels of 4.5–10 mIU/L with associated signs/symptoms.

Results

During the 69-month follow-up period, 321 patients (60%) developed overall hypothyroidism following hemithyroidectomy, and 141 ultimately required LT4S, with an overall LT4S incidence of 26.4%. The most common cause of LT4S initiation was subclinical hypothyroidism with TSH levels > 10 mIU/L. In 141 patients with LT4S, the mean maintenance dose of levothyroxine was 1.34 μg/kg, and only 6 patients (4.3%) discontinued LT4S during the follow-up. The 1-, 3-, 5-, and 7-year LT4S-free survival rates of 535 patients were 88.6%, 80.2%, 73.8%, and 69.1%, respectively. Preoperative TSH levels > 2.12 mIU/L and coexistence of Hashimoto’s thyroiditis were significantly associated with LT4S following hemithyroidectomy. The risk of LT4S increased by 1.401 times, as preoperative TSH levels increased by 1 mIU/L.

Discussion

A quarter of patients required LT4S after hemithyroidectomy for the management of hypothyroidism, with a mean maintenance levothyroxine dose of 1.34 μg/kg. The preoperative TSH level and coexistence of Hashimoto’s thyroiditis were significant predictive factors of LT4S following hemithyroidectomy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1–133.

    Article  Google Scholar 

  2. Perros P, Boelaert K, Colley S, et al. Guidelines for the management of thyroid cancer. Clin Endocrinol (Oxf). 2014;81(Suppl 1):1–122.

    Article  CAS  Google Scholar 

  3. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)—Thyroid Carcinoma v. 2. National Comprehensive Cancer Network. 2018.

  4. Su SY, Grodski S, Serpell JW. Hypothyroidism following hemithyroidectomy: a retrospective review. Ann Surg. 2009;250(6):991–4.

    Article  Google Scholar 

  5. Verloop H, Louwerens M, Schoones JW, Kievit J, Smit JW, Dekkers OM. Risk of hypothyroidism following hemithyroidectomy: systematic review and meta-analysis of prognostic studies. J Clin Endocrinol Metab. 2012;97(7):2243–55.

    Article  CAS  Google Scholar 

  6. Said M, Chiu V, Haigh PI. Hypothyroidism after hemithyroidectomy. World J Surg. 2013;37(12):2839–44.

    Article  Google Scholar 

  7. Ahn D, Sohn JH, Jeon JH. Hypothyroidism following hemithyroidectomy: incidence, risk factors, and clinical characteristics. J Clin Endocrinol Metab. 2016;101(4):1429–36.

    Article  CAS  Google Scholar 

  8. Park S, Jeon MJ, Song E, et al. Clinical features of early and late postoperative hypothyroidism after lobectomy. J Clin Endocrinol Metab. 2017;102(4):1317–24.

    Article  Google Scholar 

  9. Stoll SJ, Pitt SC, Liu J, Schaefer S, Sippel RS, Chen H. Thyroid hormone replacement after thyroid lobectomy. Surgery. 2009;146(4):554–8 (discussion 558-60).

  10. Lee DY, Seok J, Jeong WJ, Ahn SH. Prediction of thyroid hormone supplementation after thyroid lobectomy. J Surg Res. 2015;193(1):273–8.

    Article  CAS  Google Scholar 

  11. Ng P, Ho C, Tan WB, et al. Predictors of thyroxine replacement following hemithyroidectomy in a south east Asian cohort. Head Neck. 2018;41(5):1463–7.

    Article  Google Scholar 

  12. Turner MR, Camacho X, Fischer HD, et al. Levothyroxine dose and risk of fractures in older adults: nested case-control study. BMJ. 2011;342:d2238.

    Article  Google Scholar 

  13. Freudenthal B, Williams GR. Thyroid-stimulating hormone suppression in the long-term follow-up of differentiated thyroid cancer. Clin Oncol (R Coll Radiol). 2017;29(5):325–8.

    Article  CAS  Google Scholar 

  14. Shin DW, Suh B, Lim H, Yun JM, Song SO, Park Y. J-shaped association between postoperative levothyroxine dosage and fracture risk in thyroid cancer patients: a retrospective cohort study. J Bone Miner Res. 2018;33(6):1037–43.

    Article  CAS  Google Scholar 

  15. Cox C, Bosley M, Southerland LB, et al. Lobectomy for treatment of differentiated thyroid cancer: can patients avoid postoperative thyroid hormone supplementation and be compliant with the American Thyroid Association guidelines? Surgery. 2018;163(1):75–80.

    Article  Google Scholar 

  16. Col NF, Surks MI, Daniels GH. Subclinical thyroid disease: clinical applications. JAMA. 2004;291(2):239–43.

    Article  CAS  Google Scholar 

  17. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004;291(2):228–38.

    Article  CAS  Google Scholar 

  18. Jin J, Allemang MT, McHenry CR. Levothyroxine replacement dosage determination after thyroidectomy. Am J Surg. 2013;205(3):360–3 (discussion 363-4).

  19. Ha TK, Kim DW, Park HK, et al. The effect of levothyroxine discontinuation timing on postoperative hypothyroidism after hemithyroidectomy for papillary thyroid microcarcinoma. Int J Endocrinol. 2016;2016:3240727.

    Article  Google Scholar 

  20. Cooper DS, Specker B, Ho M, et al. Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry. Thyroid. 1998;8(9):737–44.

    Article  CAS  Google Scholar 

  21. Brabant G. Thyrotropin suppressive therapy in thyroid carcinoma: what are the targets? J Clin Endocrinol Metab. 2008;93(4):1167–9.

    Article  CAS  Google Scholar 

  22. Bilimoria KY, Bentrem DJ, Ko CY, et al. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg. 2007;246(3):375–81 (discussion 381-4).

  23. Barney BM, Hitchcock YJ, Sharma P, Shrieve DC, Tward JD. Overall and cause-specific survival for patients undergoing lobectomy, near-total, or total thyroidectomy for differentiated thyroid cancer. Head Neck. 2011;33(5):645–9.

    Article  Google Scholar 

  24. Li X, Zhao C, Hu D, et al. Hemithyroidectomy increases the risk of disease recurrence in patients with ipsilateral multifocal papillary thyroid carcinoma. Oncol Lett. 2013;5(4):1412–6.

    Article  Google Scholar 

  25. Park YM, Lee DY, Oh KH, et al. Clinical implications of pathologic factors after thyroid lobectomy in patients with papillary thyroid carcinoma. Oral Oncol. 2017;75:1–5.

    Article  CAS  Google Scholar 

  26. Son HJ, Kim JK, Jung YD, et al. Comparison of outcomes between hemithyroidectomy alone and hemithyroidectomy with elective unilateral central neck dissection in patients with papillary thyroid microcarcinoma. Head Neck. 2018;40(11):2449–54.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Otolaryngology-Head and Neck Surgery, School of Medicine, Kyungpook National University, Daegu, Korea

    Dongbin Ahn MD, Gil Joon Lee MD & Jin Ho Sohn MD, PhD

Authors
  1. Dongbin Ahn MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gil Joon Lee MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jin Ho Sohn MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dongbin Ahn MD.

Ethics declarations

Disclosure

None.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (TIFF 38 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ahn, D., Lee, G.J. & Sohn, J.H. Levothyroxine Supplementation Following Hemithyroidectomy: Incidence, Risk Factors, and Characteristics. Ann Surg Oncol 26, 4405–4413 (2019). https://doi.org/10.1245/s10434-019-07786-x

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-019-07786-x

Search

Navigation